Amarin Corp Plc (AMRN)

[Ajax133]

BB: You're a bit over the top. FDA will never be
obliterated or even get their wrists slapped. I
believe you're personalizing the AMRN situation,
but exacting revenge and seeking justice is a bit
much. Congress is only trying to have them redraw
guidelines dealing with more extensive off label
drug use and increase generics to be more cost effective
for ACA. Until the new pricing models are worked out I'm
suspect of any near term resolution in the negotiations
between AMRN and FDA. The negotiations include BIO, PHRMA, Congress, FDA, PBM's and Insurers. Pal, it ain't about AMRN
Reimbursement going forward will be based on patient outcome
data, individual responses, and a sliding scale based on
outcome data. You're starting to sound manic. Calm down Pal
or you're looking at significant medical problems.